Disease-modifying therapies (DMTs) are usually the first-line treatment for MS. These medications decrease the number and severity of immune system attacks and slow the natural progression of the ...

Panelist discusses how an early analysis of the mechanisms of acquired resistance to first-line treatment with amivantamab plus lazertinib vs osimertinib was presented at the European Society for ...

After diagnosis, knowing where to turn next with your breast cancer treatment can be a tough ... Radiation is a targeted, first-line therapy that destroys cancer cells in a specific area of ...

Several treatment alternatives have been investigated, such as intraperitoneal chemotherapy, alternative doublets and triplet regimens, in the effort to find an optimal first-line treatment strategy.

The company’s self-developed original new drug, Chiauranib, combined with PD - (L) 1 monoclonal antibody and standard chemotherapy for the first-line treatment of extensive stage small cell lung ...

This study confirms the efficacy (and noninferiority) of a 7-day course of ciprofloxacin for the treatment of acute pyelonephritis, even in women with severe infection or bacteremia. Shorter ...

Image credit: Michael Vi / Shutterstock. The US Food and Drug Administration (FDA) has approved Roche’s Itovebi (inavolisib) in combination with Pfizer’s Ibrance (palbociclib) and AstraZeneca’s ...

The FDA on Thursday approved Roche’s inavolisib—now to be marketed as Itovebi—for the first-line treatment of certain breast cancer patients in combination with Pfizer’s Ibrance and AstraZeneca’s ...

In most cases, your doctor will start by prescribing oral medication. Metformin is the first-line treatment for the majority of people with type 2 diabetes. Over time, you might need to add other ...

The best antibiotic to treat pneumonia will depend on several factors, such as your type of pneumonia, age, lifestyle, and medical history. Zithromax (azithromycin) is often the first-line treatment ...

Oct. 11 (UPI) --Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first once-weekly treatment for the disease. Hympavzi ...

"There have been a number of important advances in first-line treatment for NSCLC, but this is an aggressive disease, and most patients will develop progression, with limited effective treatment ...